Use of resazurin to detect mefloquine as an efflux-pump inhibitor in Pseudomonas aeruginosa and Escherichia coli

Journal of Microbiological Methods

Volumn 79, Issue 2, 2009, Pages 232-237

  Vidal Aroca, Faustino ^a   Meng, Alexandra ^a   Minz, Tanja ^a   Page, Malcolm G P ^a   Dreier, Jürg ^a  

^a BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

Author keywords

Alamar Blue; Efflux; Escherichia coli; Mefloquine; Microtiter plate; Pseudomonas aeruginosa; Resazurin; Resorufin

Indexed keywords

CHEMICAL COMPOUND; MEFLOQUINE; RESAZURIN; RESORUFIN;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; MICROTITER PLATE ASSAY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; VALIDATION STUDY; WILD TYPE;

DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; MEFLOQUINE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OXAZINES; PSEUDOMONAS AERUGINOSA; STAINING AND LABELING; XANTHENES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

EID: 70350004050     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2009.09.021     Document Type: Article

References (32)

1. Ahmed M., Borsch C.M., Neyfakh A.A., and Schuldiner S. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J. Biol. Chem. 268 (1993) 11086-11089
2. Bohnert J.A., and Kern W.V. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 49 (2005) 849-852
3. Datsenko K.A., and Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6640-6645
4. De la Campa A.G., Garcia E., Fenoll A., and Munoz R. Molecular bases of three characteristic phenotypes of pneumococcus: optochin-sensitivity, coumarin-sensitivity, and quinolone-resistance. Microb. Drug Resist. 3 (1997) 177-193
5. Dreier J. Active drug efflux in bacteria. In: Bonomo R.A., and Tolmasky M. (Eds). Enzyme-Mediated Resistance to Antibiotics (2007), Washington D.C, ASM Press 235-264
6. Fenoll A., Munoz R., Garcia E., and de la Campa A.G. Molecular basis of the optochin-sensitive phenotype of pneumococcus: characterization of the genes encoding the F0 complex of the Streptococcus pneumoniae and Streptococcus oralis H(+)-ATPases. Mol. Microbiol. 12 (1994) 587-598
7. Gallo S., Chevalier J., Mahamoud A., Eyraud A., Pages J.M., and Barbe J. 4-Alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain. Int. J. Antimicrob. Agents 22 (2003) 270-273
8. Garvey M.I., and Piddock L.J. The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob. Agents Chemother. 52 (2008) 1677-1685
9. Henry M., Alibert S., Rogier C., Barbe J., and Pradines B. Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Curr. Top. Med. Chem. 8 (2008) 563-578
10. Hoang T.T., Karkhoff-Schweizer R.R., Kutchma A.J., and Schweizer H.P. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212 (1998) 77-86
11. Hsieh P.C., Siegel S.A., Rogers B., Davis D., and Lewis K. Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6602-6606
12. Kern W.V., Steinke P., Schumacher A., Schuster S., von Baum H., and Bohnert J.A. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 57 (2006) 339-343
13. Kumar A., Chua K.L., and Schweizer H.P. Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b. Antimicrob. Agents Chemother. 50 (2006) 3460-3463
14. Kunin C.M., and Ellis W.Y. Antimicrobial activities of mefloquine and a series of related compounds. Antimicrob. Agents Chemother. 44 (2000) 848-852
15. Lewis K. In search of natural substrates and inhibitors of MDR pumps. J. Mol. Microbiol. Biotechnol. 3 (2001) 247-254
16. Lewis K., and Ausubel F.M. Prospects for plant-derived antibacterials. Nat. Biotechnol. 24 (2006) 1504-1507
17. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin. Infect. Dis. 34 (2002) 634-640
18. Lomovskaya O., Warren M.S., Lee A., Galazzo J., Fronko R., Lee M., Blais J., Cho D., Chamberland S., Renau T., Leger R., Hecker S., Watkins W., Hoshino K., Ishida H., and Lee V.J. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45 (2001) 105-116
19. O'Brien J., Wilson I., Orton T., and Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267 (2000) 5421-5426
20. Obritsch M.D., Fish D.N., MacLaren R., and Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob. Agents Chemother. 48 (2002) 4606-4610
21. Pages J.M., Masi M., and Barbe J. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 11 (2005) 382-389
22. Pannek S., Higgins P.G., Steinke P., Jonas D., Akova M., Bohnert J.A., Seifert H., and Kern W.V. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. J. Antimicrob. Chemother. 57 (2006) 970-974
23. Piddock L.J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19 (2006) 382-402
24. Piddock L.J. Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. Microbiol. 4 (2006) 629-636
25. Poole K. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob. Agents Chemother. 44 (2000) 2233-2241
26. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10 (2004) 12-26
27. Poole K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56 (2005) 20-51
28. Sanchez P., Le U., and Martinez J.L. The efflux pump inhibitor Phe-Arg-beta-naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump. J. Antimicrob. Chemother. 51 (2003) 1042-1045
29. Schumacher A., Steinke P., Bohnert J.A., Akova M., Jonas D., and Kern W.V. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J. Antimicrob. Chemother. 57 (2006) 344-348
30. Schweizer H.P. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet. Mol. Res. 2 (2003) 48-62
31. Valderramos S.G., and Fidock D.A. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 27 (2006) 594-601
32. Van Bambeke F., Pages J.M., and Lee V.J. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent patents. Anti-Infect. Drug Disc. 1 (2006) 157-175